Cargando…
Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease
Eales disease (ED) is an idiopathic inflammatory venous occlusion of the peripheral retina. As neovascularization is prominent in ED, this study attempts to look at the ratio of VEGF, the angiogenic factor, and PEDF, an anti-angiogenic factor in the vitreous of ED patients in comparison with the mac...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Humana Press Inc
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802506/ https://www.ncbi.nlm.nih.gov/pubmed/20072643 http://dx.doi.org/10.1007/s12177-009-9017-7 |
_version_ | 1782175999625003008 |
---|---|
author | Angayarkanni, Narayanasamy Selvi, Radhakrishnan Pukhraj, Rishi Biswas, Jyotirmoy Bhavesh, Shah J. Tombran-Tink, Joyce |
author_facet | Angayarkanni, Narayanasamy Selvi, Radhakrishnan Pukhraj, Rishi Biswas, Jyotirmoy Bhavesh, Shah J. Tombran-Tink, Joyce |
author_sort | Angayarkanni, Narayanasamy |
collection | PubMed |
description | Eales disease (ED) is an idiopathic inflammatory venous occlusion of the peripheral retina. As neovascularization is prominent in ED, this study attempts to look at the ratio of VEGF, the angiogenic factor, and PEDF, an anti-angiogenic factor in the vitreous of ED patients in comparison with the macular hole (MH) and Proliferative Diabetic Retinopathy (PDR). Vitreous levels of VEGF and PEDF were determined in the undiluted vitreous specimen obtained from 26 ED cases, 17 PDR, and seven patients with MH. The vitreous levels of VEGF and PEDF were estimated by ELISA. The immunohistochemistry (IHC) for VEGF and PEDF were done in the epiretinal membrane of ED and PDR case. The VEGF/PEDF ratio was found to be significantly increased in ED (p = 0.014) and PDR (p = 0.000) compared to MH. However the ratio was 3.5-fold higher in PDR than ED (p = 0.009). The IHC data on the ERM specimen from ED showed the presence of VEGF and PEDF similar to PDR. The high angiogenic potential seen as the ratio of VEGF/PEDF correlates with the peak clinical onset of the disease in the age group 21–30 years and the diseases usually self-resolves above the age of 40, which is reflected by the low ratio of VEGF/PEDF. The study shows that the VEGF/PEDF ratio is significantly increased in ED though the angiogenic potential is higher in PDR than in ED. Clinically Eales Disease is known as a self-limiting disease, while PDR is a progressive disease. |
format | Text |
id | pubmed-2802506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Humana Press Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-28025062010-01-12 Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease Angayarkanni, Narayanasamy Selvi, Radhakrishnan Pukhraj, Rishi Biswas, Jyotirmoy Bhavesh, Shah J. Tombran-Tink, Joyce J Ocul Biol Dis Infor Article Eales disease (ED) is an idiopathic inflammatory venous occlusion of the peripheral retina. As neovascularization is prominent in ED, this study attempts to look at the ratio of VEGF, the angiogenic factor, and PEDF, an anti-angiogenic factor in the vitreous of ED patients in comparison with the macular hole (MH) and Proliferative Diabetic Retinopathy (PDR). Vitreous levels of VEGF and PEDF were determined in the undiluted vitreous specimen obtained from 26 ED cases, 17 PDR, and seven patients with MH. The vitreous levels of VEGF and PEDF were estimated by ELISA. The immunohistochemistry (IHC) for VEGF and PEDF were done in the epiretinal membrane of ED and PDR case. The VEGF/PEDF ratio was found to be significantly increased in ED (p = 0.014) and PDR (p = 0.000) compared to MH. However the ratio was 3.5-fold higher in PDR than ED (p = 0.009). The IHC data on the ERM specimen from ED showed the presence of VEGF and PEDF similar to PDR. The high angiogenic potential seen as the ratio of VEGF/PEDF correlates with the peak clinical onset of the disease in the age group 21–30 years and the diseases usually self-resolves above the age of 40, which is reflected by the low ratio of VEGF/PEDF. The study shows that the VEGF/PEDF ratio is significantly increased in ED though the angiogenic potential is higher in PDR than in ED. Clinically Eales Disease is known as a self-limiting disease, while PDR is a progressive disease. Humana Press Inc 2009-03-06 /pmc/articles/PMC2802506/ /pubmed/20072643 http://dx.doi.org/10.1007/s12177-009-9017-7 Text en © The Author(s) 2009 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Angayarkanni, Narayanasamy Selvi, Radhakrishnan Pukhraj, Rishi Biswas, Jyotirmoy Bhavesh, Shah J. Tombran-Tink, Joyce Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease |
title | Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease |
title_full | Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease |
title_fullStr | Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease |
title_full_unstemmed | Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease |
title_short | Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease |
title_sort | ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in eales disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802506/ https://www.ncbi.nlm.nih.gov/pubmed/20072643 http://dx.doi.org/10.1007/s12177-009-9017-7 |
work_keys_str_mv | AT angayarkanninarayanasamy ratioofthevitreousvascularendothelialgrowthfactorandpigmentepithelialderivedfactorinealesdisease AT selviradhakrishnan ratioofthevitreousvascularendothelialgrowthfactorandpigmentepithelialderivedfactorinealesdisease AT pukhrajrishi ratioofthevitreousvascularendothelialgrowthfactorandpigmentepithelialderivedfactorinealesdisease AT biswasjyotirmoy ratioofthevitreousvascularendothelialgrowthfactorandpigmentepithelialderivedfactorinealesdisease AT bhaveshshahj ratioofthevitreousvascularendothelialgrowthfactorandpigmentepithelialderivedfactorinealesdisease AT tombrantinkjoyce ratioofthevitreousvascularendothelialgrowthfactorandpigmentepithelialderivedfactorinealesdisease |